92 related articles for article (PubMed ID: 26187744)
1. Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease.
Lawrence K; Berry B; Handshoe J; Hout D; Mazzola R; Morris SW; Saltman DL
BMC Res Notes; 2015 Jul; 8():308. PubMed ID: 26187744
[TBL] [Abstract][Full Text] [Related]
2. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.
Boi M; Todaro M; Vurchio V; Yang SN; Moon J; Kwee I; Rinaldi A; Pan H; Crescenzo R; Cheng M; Cerchietti L; Elemento O; Riveiro ME; Cvitkovic E; Bertoni F; Inghirami G;
Oncotarget; 2016 Nov; 7(48):79637-79653. PubMed ID: 27793034
[TBL] [Abstract][Full Text] [Related]
4. Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node.
Norimatsu Y; Akatsuka T; Matsuoka A; Hamada T; Mori I; Shiomi T; Mori N; Onishi K; Togashi Y; Inoue N; Takeuchi K; Sugaya M
J Dermatol; 2024 Jan; 51(1):120-124. PubMed ID: 37753577
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
Tsuyama N; Sakamoto K; Sakata S; Dobashi A; Takeuchi K
J Clin Exp Hematop; 2017; 57(3):120-142. PubMed ID: 29279550
[TBL] [Abstract][Full Text] [Related]
6. Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group.
Luedersen J; Stadt UZ; Richter J; Oschlies I; Klapper W; Rosenwald A; Kalinova M; Simonitsch-Klupp I; Siebert R; Zimmermann M; Qi M; Nakel J; Scheinemann K; Knörr F; Attarbaschi A; Kabickova E; Woessmann W; Damm-Welk C
Br J Haematol; 2024 May; 204(5):1894-1898. PubMed ID: 38279625
[TBL] [Abstract][Full Text] [Related]
7. Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis.
Mduff FK; Hook CE; Tooze RM; Huntly BJ; Pandolfi PP; Turner SD
Lab Invest; 2011 Sep; 91(9):1298-303. PubMed ID: 21709672
[TBL] [Abstract][Full Text] [Related]
8. Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma.
Mu W; Zhang M; Hu G; Han Y; Mao X; Chen C; Shen K; Dai Z; Zhu X; Zhou X; Huang L; Ao Q; Xiao M
Front Immunol; 2023; 14():1280007. PubMed ID: 38143760
[TBL] [Abstract][Full Text] [Related]
9. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
Jaye DL; Feldman AL
Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
[No Abstract] [Full Text] [Related]
10. Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function.
Zhang Q; Basappa J; Wang HY; Nunez-Cruz S; Lobello C; Wang S; Liu X; Chekol S; Guo L; Ziober A; Nejati R; Shestov A; Feldman M; Glickson JD; Turner SD; Blair IA; Van Dang C; Wasik MA
Leukemia; 2023 Dec; 37(12):2436-2447. PubMed ID: 37773266
[TBL] [Abstract][Full Text] [Related]
11. ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.
George GV; Wallace DS; Wang Y; Carney J; Elsadawi M; Burack WR; Evans AG; Barr PM; Velez MJ; El Hussein S
Histopathology; 2024 Apr; 84(5):900-902. PubMed ID: 38032068
[No Abstract] [Full Text] [Related]
12. Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin.
Nakai R; Fukuhara S; Maeshima AM; Kim SW; Ito Y; Hatta S; Suzuki T; Yuda S; Makita S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Clin Case Rep; 2019 Dec; 7(12):2500-2504. PubMed ID: 31893088
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic large cell lymphoma with ALK::ATIC fusion mimicking a histiocytic sarcoma debuting as an anterior thoracic soft tissue tumor with exceptional clinicopathological, morphological and molecular features.
García-Muñiz JA; Vilches-Cisneros N; Flores-Gutiérrez JP; Barboza-Quintana O
Thorac Cancer; 2024 May; 15(13):1103-1105. PubMed ID: 38523398
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of minimal disseminated disease assessed using digital polymerase chain reaction for 3'
Fukano R; Iijima-Yamashita Y; Iwafuchi H; Nakazawa A; Saito AM; Takimoto T; Sekimizu M; Suehiro Y; Yamasaki T; Hasegawa S; Mori T; Horibe K
Haematologica; 2024 Feb; 109(2):652-656. PubMed ID: 37675509
[No Abstract] [Full Text] [Related]
15.
Xiao A; Shahmarvand N; Nagy A; Kumar J; Van Ziffle J; Devine P; Huang F; Lezama L; Li P; Ohgami RS
Front Oncol; 2023; 13():1174606. PubMed ID: 37305584
[TBL] [Abstract][Full Text] [Related]
16. Papillary thyroid carcinoma coexisting with ALK-negative anaplastic large-cell lymphoma: An exceptional clinical case report.
Guo Z; Ali H; Wang S; Li J
Asian J Surg; 2024 Mar; 47(3):1589-1591. PubMed ID: 38087686
[No Abstract] [Full Text] [Related]
17. The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation.
Unger C; Kiss I; Vasas A; Lajter I; Kramer N; Atanasov AG; Nguyen CH; Chatuphonprasert W; Brenner S; Krieger S; McKinnon R; Peschel A; Kain R; Saiko P; Szekeres T; Kenner L; Hassler MR; Diaz R; Frisch R; Dirsch VM; Jäger W; de Martin R; Bochkov VN; Passreiter CM; Peter-Vörösmarty B; Mader RM; Grusch M; Dolznig H; Kopp B; Zupko I; Hohmann J; Krupitza G
Phytomedicine; 2015 Aug; 22(9):862-74. PubMed ID: 26220634
[TBL] [Abstract][Full Text] [Related]
18. Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain.
He D; Chen H; Muramatsu H; Lasek AW
J Neurochem; 2015 Nov; 135(3):508-21. PubMed ID: 26206265
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of
Agarwal I; Sabatini L; Alikhan MB
Front Oncol; 2020; 10():730. PubMed ID: 32457846
[No Abstract] [Full Text] [Related]
20. TRAF1 Signaling in Human Health and Disease.
Edilova MI; Abdul-Sater AA; Watts TH
Front Immunol; 2018; 9():2969. PubMed ID: 30619326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
